General Information of the Compound
Compound ID
CP0108340
Compound Name
N-(2-hydroxyethyl)octadecanamide
    Show/Hide
Synonyms
N-stearoylethanolamine
SEA
stearoylethanolamide
    Show/Hide
Structure
Formula
C20H41NO2
Molecular Weight
327.553
Canonical SMILES
CCCCCCCCCCCCCCCCCC(=O)NCCO
    Show/Hide
InChI
InChI=1S/C20H41NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h22H,2-19H2,1H3,(H,21,23)
    Show/Hide
InChIKey
OTGQIQQTPXJQRG-UHFFFAOYSA-N
CAS
8038-89-9
111-57-9
Physicochemical Property
logP
5.3564
Rotatable Bonds
18
Heavy Atom Count
23
Polar Areas
49.33
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 27902
SID: 14753032
ChEMBL ID
CHEMBL171447
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06137, Transient receptor potential cation channel subfamily V member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( SEA )
Drug Name SEA
Target(s)
Glucose-dependent insulinotropic receptor (GPR119)
Agonist